Your browser doesn't support javascript.
loading
Combined tazemetostat and MAPKi enhances differentiation of papillary thyroid cancer cells harbouring BRAFV600E by synergistically decreasing global trimethylation of H3K27.
Fu, Hao; Cheng, Lin; Sa, Ri; Jin, Yuchen; Chen, Libo.
Affiliation
  • Fu H; Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
  • Cheng L; Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
  • Sa R; Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
  • Jin Y; Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
  • Chen L; Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
J Cell Mol Med ; 24(6): 3336-3345, 2020 03.
Article in En | MEDLINE | ID: mdl-31970877

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyridones / Benzamides / Biphenyl Compounds / Histones / Cell Differentiation / Morpholines / Proto-Oncogene Proteins B-raf / Protein Kinase Inhibitors / Thyroid Cancer, Papillary Limits: Humans Language: En Journal: J Cell Mol Med Journal subject: BIOLOGIA MOLECULAR Year: 2020 Type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyridones / Benzamides / Biphenyl Compounds / Histones / Cell Differentiation / Morpholines / Proto-Oncogene Proteins B-raf / Protein Kinase Inhibitors / Thyroid Cancer, Papillary Limits: Humans Language: En Journal: J Cell Mol Med Journal subject: BIOLOGIA MOLECULAR Year: 2020 Type: Article Affiliation country: China